Positive News Coverage and Bluesky Skepticism Have Been Diverging on AI in Healthcare for Weeks Now

A Nature study circulating on Bluesky this week found that misleading AI explanations significantly degraded diagnostic accuracy in medical students, while correct explanations offered no measurable improvement. The post drew four likes — a modest number, but notable for a feed where most AI-in-healthcare content gets zero engagement regardless of sentiment. The finding landed quietly, but it captures what's actually happening in this conversation: the headline story is one of revolutionary promise, and the lived-experience story is one of compounding doubt.

The gap between those two stories has been remarkably stable. Across multiple days of signals, news coverage has clustered at the enthusiastic end of the spectrum — cancer diagnosis markets projecting 27% annual growth, Amazon putting a doctor in your pocket, Fei-Fei Li working on healthcare AI. Bluesky has consistently sat on the opposite end, and not because the community there is reflexively anti-technology. The skepticism is granular. One user notes that a ChatGPT-powered medical translation study produced exactly zero working discharge summaries despite widespread promotion. Another flags that AI-generated emergency alerts in Baltimore are coming with the caveat that information may be incorrect. A third points out the internal contradiction in papers that claim LLMs will enable diagnostic precision in the same breath as admitting LLMs don't reliably know facts.

What makes this divergence durable rather than just a left-brain-right-brain split between journalists and social media users is the specific anxiety underneath it. The most politically charged Bluesky posts aren't about whether AI can read an MRI — they're about who controls the AI and what it's being used to decide. Posts about the VA testing AI to reduce veteran access to treatment, about Palantir gaining entry to medical records while also building deportation infrastructure, about patients being routed through third-party algorithmic approval systems before receiving care: these aren't arguments about technical accuracy. They're arguments about power. The question isn't whether AI can diagnose cancer. It's whether the entity deploying the AI has your interests at heart.

There's a quieter thread running through the Bluesky posts that doesn't fit neatly into either camp. One transplant patient describes using AI to write an incident report against their healthcare provider — not because they trust AI, but because they're burned out and need every tool available to fight a system that's already failing them. Another user says they're firmly anti-AI with one exception: disability aids and medical research. A third admits they don't know how long they can resist adopting AI tools without risking their job, and their job is what keeps them insured. These aren't ideological positions. They're people doing triage. The AI conversation in healthcare increasingly belongs to people who don't have the luxury of a clean opinion.

The news cycle will keep publishing market projections and breakthrough announcements, and those announcements will keep outpacing the evidence. That's not cynicism — it's the consistent pattern here. What's shifting is that the people pushing back are getting more specific. Vague fears about AI replacing doctors are giving way to documented failures, named institutions, and pointed questions about regulatory capture. The optimists have the press releases. The skeptics are accumulating receipts.